Chemoinformaics analysis of (Z)-gamma-bisabolene
| Molecular Weight | 204.357 | nRot | 3 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 8 |
| Exact Molecular Weight | 204.188 | nRing | 1 |
| Solubility: LogS | -5.106 | nHRing | 0 |
| Solubility: LogP | 5.913 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.556 |
| Synth | 3.256 |
| Natural Product Likeliness | 2.782 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.964 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.568 |
| MDCK | 0.0000164 |
| BBB | 0.363 |
| PPB | 0.973629 |
| VDSS | 5.795 |
| FU | 0.0281043 |
| CYP1A2-inh | 0.908 |
| CYP1A2-sub | 0.274 |
| CYP2c19-inh | 0.477 |
| CYP2c19-sub | 0.481 |
| CYP2c9-inh | 0.511 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.084 |
| CYP2d6-sub | 0.451 |
| CYP3a4-inh | 0.215 |
| CYP3a4-sub | 0.212 |
| CL | 16.815 |
| T12 | 0.334 |
| hERG | 0.029 |
| Ames | 0.002 |
| ROA | 0.005 |
| SkinSen | 0.927 |
| Carcinogencity | 0.434 |
| EI | 0.938 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.80714 |